Regulations.gov document
Attachment 2 - "Orange Book: Approved Drug Products With Therapeutic Equivalence…
Supporting & Related Material · FDA-2011-P-0047 · posted Mar 9, 2011
Key facts
| Document ID | FDA-2011-P-0047-0009 |
|---|---|
| Title | Attachment 2 - "Orange Book: Approved Drug Products With Therapeutic Equivalence Evaluations (Meclizine)" - [InvaGen Pharmaceuticals, Inc. - Amendment] re FDA-2011-P-0047-0007 |
| Document type | Supporting & Related Material |
| Subtype | AMD-(Supporting and Related Material) |
| Agency | FDA |
| Docket | FDA-2011-P-0047 |
| Posted | Mar 9, 2011 |
| Effective date | Feb 24, 2011 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: